-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Socioeconomic factors are important factors in the occurrence of strok.
MetS (metabolic syndrome) is a group of comorbidities that increase the risk of cardiovascular diseas.
Several previous studies have reported that lower socioeconomic status increases the risk of MetS and its associated risk factors and diseases such as hypertension, dyslipidemia, and type 2 diabete.
The researchers used the NHS National Sample Cohort Database from 2006 to 2015. The mediating variable was the number of simultaneously diagnosed major MetS components (two or more/three or more.
A total of 213,526 people were included in this study, with a follow-up of 1,690,663 person-year.
Middle income OR=05 (95%CI 02-08);
Low income OR=09 (95%CI 05-12);
Medicaid beneficiaries OR=39 (95%CI 32-47.
Lower income levels were significantly associated with higher stroke risk compared with higher income groups:
Among Medicaid beneficiaries, co-diagnosing major metabolic components played an important mediating role between income level and stroke incidence, with a 26% mediating role when diagnosed with two or more diseases When more than three diseases were diagnosed, there was a mediating effect of 21.
In this study, low income was an important risk factor for the simultaneous diagnosis of major MetS components and strok.
Original source:
Jeong S, Cho SI, Kong S.
